You’ll find here the latest news and insights about Real4Reg.
If you want to receive all updates directly in your email inbox, you can subscribe to our newsletter. Additionally, feel free to explore our archive for past newsletters.
-
Real4Reg study received an ENCePP Seal
Read more: Real4Reg study received an ENCePP SealThe Real4Reg study was registered in the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) database, a network coordinated by the European Medicines Agency. Following its adherence to the ENCePP Code of Conduct and internationally recognized guidelines, the Real4Reg study has been awarded an ENCePP Seal.
-
Real4Reg Consortium Meeting in Copenhagen
Read more: Real4Reg Consortium Meeting in Copenhagen
The Real4Reg consortium had its first hybrid meeting in the Danish capital city. The gathering brought together all consortium partners and advisory board members for productive discussions and presentations on the progress of the work packages and was hosted by the Danish Medicines Agency (DKMA) in collaboration with the Consortium coordinator, the Federal Institute for…
-
Real4Reg – a new European research project on real-world data
Read more: Real4Reg – a new European research project on real-world data
Regulatory and health technology assessment (HTA) agencies, academic institutions and patient organisations from six EU countries will improve the use of real-world data (RWD) in regulatory decision-making under a new project funded by the Horizon Europe Programme.